DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
von Minckwitz G, Schneeweiss A, Loibl S, Salat C, Denkert C, Rezai M. et al.
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): A randomised phase 2 trial.
Lancet Oncol 2014;
15: 747-56
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.